Clinuvel Pharmaceuti
CUV
End-of-day quote AUSTRALIAN SECURITIES EXCHANGE LIMITED - 07/19
9.89AUD
-10.09%
Prev.11.0000
Open11.0000
High11.0000
Low9.4300
Volume49 394
Company
Clinuvel Pharmaceuticals Ltd. operates as a global biopharmaceutical company, which is focused on the development of SCENESSE, its proprietary photoprotective drug.It also focuses on developing drugs for the treatment of various skin disorders.The company was founded by Robert Thomas Dorr on...
Sector :
Biopharmaceuticals
Calendar :
2018-08-29 Earnings Release
Latest news
06/25FDA to Review Australian Drug for Genetic Disorder of Absolute Light Intolerance
GL
06/25CLINUVEL PHARMACEUTICALS : completes SCENESSE FDA Filing
PU
02/21CLINUVEL PHARMACEUTICALS : unveils new global positioning
AQ
02/20CLINUVEL unveils new global positioning
GL
01/31CLINUVEL PHARMACEUTICALS : Appendix 4C
PU
01/29CLINUVEL PHARMACEUTICALS : appoints US based Director
PU
2017CLINUVEL PHARMACEUTICALS : Appendix 4C - Quarterly report
PU
2017CLINUVEL PHARMACEUTICALS : Appendix 4C
PU
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance12,013,012,9
Spread/Res.-18%-24%-23%
Spread/Supp.-5,4%-1,1%11%
Support10,510,08,92